CD276 Protein (C-His, Cynomolgus)

1.Immobilized Anti-B7-H3 (Research Grade Enoblituzumab biosimilar) at 2 μg/mL (100 μL/well) can bind Recombinant Cynomolgus B7-H3 / CD276 Protein (ECD, His Tag) (Cat: 90806-C08H), the EC50 is 2.7-9 ng/mL (QC tested) . 2.Immobilized Recombinant Cynomolgus B7-H3 / CD276 Protein (ECD, His Tag) (Cat: 90806-C08H) at 2 μg/mL (100 μL/well) can bind anti-B7-H3 (Research Grade Enoblituzumab biosimilar), the EC50 is 2.6 ng/mL (Routinely tested) .

The recombinant cynomolgus CD276 consists of 448 amino acids and predicts a molecular mass of 48.5 kDa. As a result of glycosylation, it migrates as an approximately 68.3 kDa band in SDS-PAGE under reducing conditions.